Two Sigma Advisers’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-3,400
Closed -$230K – 2791
2021
Q1
$230K Buy
+3,400
New +$236K ﹤0.01% 2316
2020
Q1
– Sell
-12,400
Closed -$811K – 2613
2019
Q4
$811K Buy
+12,400
New +$851K ﹤0.01% 1668
2017
Q1
– Sell
-11,300
Closed -$505K – 2509
2016
Q4
$505K Sell
11,300
-16,900
-60% -$749K ﹤0.01% 1870
2016
Q3
$1.34M Buy
+28,200
New +$1.46M 0.01% 1211
2014
Q3
– Sell
-105,100
Closed -$2.62M – 2754
2014
Q2
$2.62M Buy
105,100
+69,500
+195% +$1.52M 0.02% 696
2014
Q1
$740K Buy
35,600
+21,000
+144% +$457K 0.01% 1327
2013
Q4
$325K Buy
+14,600
New +$297K ﹤0.01% 1860
2013
Q3
– Sell
-17,700
Closed -$367K – 2486
2013
Q2
$367K Buy
+17,700
New +$396K 0.01% 1568

Other funds holding CONE

Two Sigma Advisers's CONE Position: Q2 2021 in Review

Two Sigma Advisers sold out of CyrusOne Inc Common Stock (CONE) in Q2 2021, closing a stake of 3,400 shares — an estimated $230K sold.

Two Sigma Advisers first reported a position in CONE in Q2 2013 and held it in 8 quarters. The position peaked at $2.62M in Q2 2014. 419 funds tracked by Wall St. Rank hold CONE as of Q2 2021.

  • Two Sigma Advisers reported no remaining CyrusOne Inc Common Stock position as of Q2 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 3,400 CyrusOne Inc Common Stock shares in Q2 2021, an estimated $230K.
  • Two Sigma Advisers first reported a position in CyrusOne Inc Common Stock in Q2 2013 and held it in 8 quarters.
  • Two Sigma Advisers's CyrusOne Inc Common Stock position peaked at $2.62M in Q2 2014.
  • 419 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q2 2021.

Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.